70 related articles for article (PubMed ID: 22226680)
1. The effect of pituitary adenylate cyclase-activating polypeptide on elevated plus maze behavior and hypothermia induced by morphine withdrawal.
Lipták N; Dochnal R; Babits A; Csabafi K; Szakács J; Tóth G; Szabó G
Neuropeptides; 2012 Feb; 46(1):11-7. PubMed ID: 22226680
[TBL] [Abstract][Full Text] [Related]
2. Increased elevated plus maze open-arm time in mice during naloxone-precipitated morphine withdrawal.
Hodgson SR; Hofford RS; Norris CJ; Eitan S
Behav Pharmacol; 2008 Dec; 19(8):805-11. PubMed ID: 19020415
[TBL] [Abstract][Full Text] [Related]
3. The effects of pituitary adenylate cyclase-activating polypeptide on acute and chronic morphine actions in mice.
Mácsai M; Pataki I; Tóth G; Szabó G
Regul Pept; 2002 Nov; 109(1-3):57-62. PubMed ID: 12409215
[TBL] [Abstract][Full Text] [Related]
4. Obestatin prevents analgesic tolerance to morphine and reverses the effects of mild morphine withdrawal in mice.
Lipták N; Dochnal R; Csabafi K; Szakács J; Szabó G
Regul Pept; 2013 Sep; 186():77-82. PubMed ID: 23891980
[TBL] [Abstract][Full Text] [Related]
5. Increased elevated plus maze open-arm time in mice during spontaneous morphine withdrawal.
Buckman SG; Hodgson SR; Hofford RS; Eitan S
Behav Brain Res; 2009 Feb; 197(2):454-6. PubMed ID: 18955087
[TBL] [Abstract][Full Text] [Related]
6. Hydrogen-rich saline attenuates anxiety-like behaviors in morphine-withdrawn mice.
Wen D; Zhao P; Hui R; Wang J; Shen Q; Gong M; Guo H; Cong B; Ma C
Neuropharmacology; 2017 May; 118():199-208. PubMed ID: 28359771
[TBL] [Abstract][Full Text] [Related]
7. [Afobazole decreases severity of morphine withdrawal syndrome: experimental evidence].
Konstantinopol'skiĭ MA; Cherniakova IV
Eksp Klin Farmakol; 2011; 74(10):12-6. PubMed ID: 22238980
[TBL] [Abstract][Full Text] [Related]
8. Baclofen prevents the elevated plus maze behavior and BDNF expression during naloxone precipitated morphine withdrawal in male and female mice.
Pedrón VT; Varani AP; Balerio GN
Synapse; 2016 May; 70(5):187-97. PubMed ID: 26789010
[TBL] [Abstract][Full Text] [Related]
9. Plasma malondialdehyde levels and opiate withdrawal signs observed in rats treated with morphine plus naloxone: effects of alpha-lipoic acid administration.
Pinelli A; Cighetti G; Trivulzio S
Fundam Clin Pharmacol; 2008 Aug; 22(4):439-45. PubMed ID: 18705754
[TBL] [Abstract][Full Text] [Related]
10. Naloxone-precipitated withdrawal enhances ERK phosphorylation in prefrontal association cortex and accumbens nucleus of morphine-dependent mice.
Li T; Hou Y; Cao W; Yan CX; Chen T; Li SB
Neurosci Lett; 2010 Jan; 468(3):348-52. PubMed ID: 19922770
[TBL] [Abstract][Full Text] [Related]
11. Influence of ATP-dependent K+ channels on nicotine-induced inhibition of withdrawal in morphine-dependent mice.
Zarrindast MR; Mohajeri S
Eur J Pharmacol; 2006 Dec; 552(1-3):90-8. PubMed ID: 17049514
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the effects of digoxin, ouabain and milrinone on naloxone-precipitated withdrawal syndrome in mice.
Bai YL; Chu QJ; Li J; Chen YY; Li WJ; Zhang Q
Eur J Pharmacol; 2012 Nov; 694(1-3):69-74. PubMed ID: 22960325
[TBL] [Abstract][Full Text] [Related]
13. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
Rehni AK; Bhateja P; Singh TG; Singh N
Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
[TBL] [Abstract][Full Text] [Related]
14. Dansyl-PQRamide, a putative antagonist of NPFF receptors, reduces anxiety-like behavior of ethanol withdrawal in a plus-maze test in rats.
Kotlinska J; Pachuta A; Bochenski M; Silberring J
Peptides; 2009 Jun; 30(6):1165-72. PubMed ID: 19463751
[TBL] [Abstract][Full Text] [Related]
15. Quantitation of physical dependence in mice by naloxone-precipitated jumping after a single dose of morphine.
Smits SE
Res Commun Chem Pathol Pharmacol; 1975 Apr; 10(4):651-61. PubMed ID: 1171511
[TBL] [Abstract][Full Text] [Related]
16. Mianserin attenuates naloxone-precipitated withdrawal signs in rats acutely or chronically dependent upon morphine.
Neal BS; Sparber SB
J Pharmacol Exp Ther; 1986 Jan; 236(1):157-65. PubMed ID: 3001281
[TBL] [Abstract][Full Text] [Related]
17. Diverse effects of intrathecal pituitary adenylate cyclase-activating polypeptide on nociceptive transmission in mice spinal cord.
Shimizu T; Katahira M; Sugawara H; Inoue K; Miyata A
Regul Pept; 2004 Dec; 123(1-3):117-22. PubMed ID: 15518901
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptide Y attenuates naloxone-precipitated morphine withdrawal via Y5-like receptors.
Woldbye DP; Klemp K; Madsen TM
J Pharmacol Exp Ther; 1998 Feb; 284(2):633-6. PubMed ID: 9454808
[TBL] [Abstract][Full Text] [Related]
19. Antagonism by naloxone of morphine-induced single-dose dependence and antinociception in mice.
Smits SE
Res Commun Chem Pathol Pharmacol; 1976 Dec; 15(4):689-96. PubMed ID: 12548
[TBL] [Abstract][Full Text] [Related]
20. Central administration of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide differentially regulates energy metabolism in chicks.
Tachibana T; Oikawa D; Adachi N; Boswell T; Furuse M
Comp Biochem Physiol A Mol Integr Physiol; 2007 May; 147(1):156-64. PubMed ID: 17291802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
